The all-staff meeting at the beginning of each year is a special time to bring the entire FarmaMondo family together virtually. Colleagues from every part of the Group—Latin America, Asia, the Middle East, Europe, and the head office in Switzerland—connect with one another.
For Group CEO Yaron Spigel, it’s an opportunity to thank everyone for the incredible progress and results achieved in 2024. For the sixth year in a row, we’re celebrating high double-digit growth. More importantly, we’re celebrating the impact we’ve had on orphan and oncology patients. For example, in one rare paediatric oncology condition, we’ve treated 1,000 patients over six years.
This meeting is also a time to unite, share, and align our objectives for 2025. All our goals are focused on one core purpose: serving more patients with essential medicines around the world, particularly in emerging markets.
Everyone’s dedication and expertise are crucial to achieving this goal across all our activities: medical information and education, regulatory navigation in diverse markets, market access and treatment coverage through private or public payers, charities, or commercial channels, patient support, and logistics to ensure medicines reach patients’ bedside. Every effort is key to making our vision a reality, every day.
We use cookies that are strictly necessary to operate this website.
We also use optional cookies to improve your accessibility to our website and its functionality, to analyse and track your use of our website and to give you the best possible user experience.
You will need to activate optional cookies. For more detailed information on our use of cookies on this website, please read our Cookie Policy, which also explains how to customise your Cookies settings.
You can also accept all our cookies or customise your Cookies settings by clicking on the buttons provided below.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
For Group CEO Yaron Spigel, it’s an opportunity to thank everyone for the incredible progress and results achieved in 2024. For the sixth year in a row, we’re celebrating high double-digit growth. More importantly, we’re celebrating the impact we’ve had on orphan and oncology patients. For example, in one rare paediatric oncology condition, we’ve treated 1,000 patients over six years.
This meeting is also a time to unite, share, and align our objectives for 2025. All our goals are focused on one core purpose: serving more patients with essential medicines around the world, particularly in emerging markets.
Everyone’s dedication and expertise are crucial to achieving this goal across all our activities: medical information and education, regulatory navigation in diverse markets, market access and treatment coverage through private or public payers, charities, or commercial channels, patient support, and logistics to ensure medicines reach patients’ bedside. Every effort is key to making our vision a reality, every day.